199 related articles for article (PubMed ID: 12143255)
1. Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer.
Melichar B; Touskova M; Vesely P
Hepatogastroenterology; 2002; 49(46):967-70. PubMed ID: 12143255
[TBL] [Abstract][Full Text] [Related]
2. [Changes of lymphocyte subsets before and after chemotherapy in colorectal carcinoma patients].
Zhang GQ; Zhao H; Wen XY; Li JY; Wu LL; Jiao SC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):155-60. PubMed ID: 23643003
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II combined chemoimmunotherapy with carcinoembryonic antigen-derived HLA-A2-restricted CAP-1 peptide and irinotecan, 5-fluorouracil, and leucovorin in patients with primary metastatic colorectal cancer.
Weihrauch MR; Ansén S; Jurkiewicz E; Geisen C; Xia Z; Anderson KS; Gracien E; Schmidt M; Wittig B; Diehl V; Wolf J; Bohlen H; Nadler LM
Clin Cancer Res; 2005 Aug; 11(16):5993-6001. PubMed ID: 16115944
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T-lymphocytopenia and systemic immune activation in patients with primary and secondary liver tumours.
Melichar B; Tousková M; Solichová D; Králicková P; Kopecký G
Scand J Clin Lab Invest; 2001; 61(5):363-70. PubMed ID: 11569483
[TBL] [Abstract][Full Text] [Related]
5. Low-dose chemotherapy with leucovorin plus 5-fluorouracil for colorectal cancer can maintain host immunity.
Kobayashi R; Yoshimatsu K; Yokomizo H; Katsube T; Ogawa K
Anticancer Res; 2007; 27(1B):675-9. PubMed ID: 17348459
[TBL] [Abstract][Full Text] [Related]
6. Phenotype of peripheral blood leukocytes and survival of patients with metastatic colorectal cancer.
Vesely P; Tousková M; Melichar B
Int J Biol Markers; 2005; 20(2):126-33. PubMed ID: 16011044
[TBL] [Abstract][Full Text] [Related]
7. Changes of immunological parameters reflect quality of life-related toxicity during chemotherapy in patients with advanced colorectal cancer.
Yoshimatsu K; Kuhara K; Itagaki H; Aizawa M; Yokomizo H; Fujimoto T; Otani T; Osawa G; Kobayashi R; Ogawa K
Anticancer Res; 2008; 28(1B):373-8. PubMed ID: 18383872
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
10. Immune characterization of metastatic colorectal cancer patients post reovirus administration.
Parakrama R; Fogel E; Chandy C; Augustine T; Coffey M; Tesfa L; Goel S; Maitra R
BMC Cancer; 2020 Jun; 20(1):569. PubMed ID: 32552875
[TBL] [Abstract][Full Text] [Related]
11. [Initial results of randomized studies of metastatic colorectal carcinoma urge careful and controlled use of CPT-11].
Klautke G; Fietkau R
Strahlenther Onkol; 2002 Mar; 178(3):163-4. PubMed ID: 11962194
[No Abstract] [Full Text] [Related]
12. [Irinotecan plus fluorouracil and leucovorin for advanced colorectal cancer].
Motomura S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():360-3. PubMed ID: 14574913
[No Abstract] [Full Text] [Related]
13. Regional administration of irinotecan in combination with 5-fluorouracil and leucovorin in patients with colorectal cancer liver metastases--a pilot experience.
Melichar B; Dvorák J; Jandík P; Tousková M; Malírová E; Megancová J; Voboril Z
Hepatogastroenterology; 2001; 48(42):1721-6. PubMed ID: 11813608
[TBL] [Abstract][Full Text] [Related]
14. Phenotype of peripheral blood leukocytes and survival of patients with metastatic colorectal cancer.
Vesely P; Touskov M; Melichar B
Int J Biol Markers; 2005; 20(2):126-133. PubMed ID: 28207139
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983.
Tanis E; Julié C; Emile JF; Mauer M; Nordlinger B; Aust D; Roth A; Lutz MP; Gruenberger T; Wrba F; Sorbye H; Bechstein W; Schlag P; Fisseler A; Ruers T
Eur J Cancer; 2015 Nov; 51(17):2708-17. PubMed ID: 26342674
[TBL] [Abstract][Full Text] [Related]
16. Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: a phase II trial.
Souglakos J; Vardakis N; Androulakis N; Kakolyris S; Kourousis C; Mavroudis D; Pallis A; Agelaki S; Kalbakis K; Georgoulias V
Dig Dis; 2007; 25(1):100-5. PubMed ID: 17384515
[TBL] [Abstract][Full Text] [Related]
17. Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial.
Souglakos J; Mavroudis D; Kakolyris S; Kourousis Ch; Vardakis N; Androulakis N; Agelaki S; Kalbakis K; Tsetis D; Athanasiadis N; Samonis G; Georgoulias V
J Clin Oncol; 2002 Jun; 20(11):2651-7. PubMed ID: 12039926
[TBL] [Abstract][Full Text] [Related]
18. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
[TBL] [Abstract][Full Text] [Related]
19. The peripheral blood leukocyte phenotype in patients with breast cancer: effect of doxorubicin/paclitaxel combination chemotherapy.
Melichar B; Tousková M; Dvorák J; Jandík P; Kopecký O
Immunopharmacol Immunotoxicol; 2001 May; 23(2):163-73. PubMed ID: 11417845
[TBL] [Abstract][Full Text] [Related]
20. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.
Falcone A; Masi G; Allegrini G; Danesi R; Pfanner E; Brunetti IM; Di Paolo A; Cupini S; Del Tacca M; Conte P
J Clin Oncol; 2002 Oct; 20(19):4006-14. PubMed ID: 12351598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
